Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus

In recent years, direct oral anticoagulants (DOAC) have accumulated evidence of efficacy and safety in various clinical scenarios and are approved for a wide spectrum of indications. Still, they are currently used off-label for left ventricular thrombus owing to a paucity of evidence. For the same r...

Full description

Bibliographic Details
Main Authors: Minerva Codruta Badescu, Victorita Sorodoc, Catalina Lionte, Anca Ouatu, Raluca Ecaterina Haliga, Alexandru Dan Costache, Oana Nicoleta Buliga-Finis, Ioan Simon, Laurentiu Sorodoc, Irina-Iuliana Costache, Ciprian Rezus
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Personalized Medicine
Subjects:
direct oral anticoagulants
left ventricular thrombus
myocarditis
hypertrophic cardiomyopathy
COVID-19
Online Access:https://www.mdpi.com/2075-4426/13/1/158

Internet

https://www.mdpi.com/2075-4426/13/1/158

Similar Items